Ratings Humana Inc.

Equities

Market Closed - Nyse Other stock markets 01:30:02 25/06/2025 am IST			5-day change	1st Jan Change
238.79 ^USD	+1.76%		-1.10%	-5.88%

24/06	Humana Inc. Expands Science-Based Targets with New SBTi-Validated Target	CI
24/06	Humana Sets New Scope 3 Asset Class Level Target Aiming to Reduce Emissions From Lending Activities	MT

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
The company has a good ESG score relative to its sector, according to MSCI.

The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.28 for the 2025 fiscal year.
The company has a low valuation given the cash flows generated by its activity.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The opinion of analysts covering the stock has improved over the past four months.

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
The company is not the most generous with respect to shareholders' compensation.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Over the past twelve months, analysts' opinions have been revised negatively.

Source: Surperformance

Source: MSCI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Global Valuation (Composite)	Capi.($)
HUMANA INC.		2.83TCr
UNITEDHEALTH GROUP INC.		27TCr
CIGNA		8.47TCr
ELEVANCE HEALTH, INC.		8.41TCr
CENTENE CORPORATION		2.66TCr
MOLINA HEALTHCARE, INC.		1.58TCr
ALIGNMENT HEALTHCARE, INC.	-	276.39Cr
PROGYNY, INC.		178.21Cr
CLOVER HEALTH INVESTMENTS, CORP.	-	144.02Cr
Average		5.76TCr
Weighted average by Cap.